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ABSTRAK 
Objektif: 
Kajian ini bertujuan untuk menentukan ketepatan penggunaan ultrasound di dalam 
membuat diagnose “placenta accreta‟ di kalangan pesakit yang mengalami “placenta 
praevia‟ dan pernah menjalani pembedahan rahim sebelumnya. Kajian ini juga 
dijalankan bagi menganalisa kadar morbiditi pesakit yang mengalami “placenta accreta‟ 
dibandingkan dengan pesakit yang tidak mengalaminya.  
Kaedah Kajian:  
Kajian ini merupakan kajian retrospektif yang merangkumi para pesakit yang 
mengalami keadaan “placenta praevia‟ dan pernah menjalani pembedahan melibatkan 
rahim seperti pembedahan Caesarean, prosedur berkaitan keguguran, pembedahan 
fibroid atau prosedur penyingkiran manual plasenta yang melahirkan bayi di Hospital 
Universiti Sains Malaysia, di antara Januari 2005 hingga Disember 2015. Sistem rekod 
hospital telah disemak dan diteliti untuk mengenal pasti pesakit dengan diagnosis 
“placenta praevia‟ selepas usia kandungan 28 minggu dan pernah menjalani 
pembedahan rahim. Sensitiviti, kekhususan, nilai ramalan positif (PPV) dan nilai 
ramalan negatif (NPV) ultrasound dalam diagnosis “placenta accreta‟ telah dianalisis.  
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Keputusan:  
Daripada 80 pesakit dimasukkan dalam kajian ini, 15 orang  daripada mereka (18.75%) 
telah disahkan menghidap “placenta accreta”. Sensitiviti dan kekhususan ultrasound 
dalam diagnosis “placenta accreta” masing-masing adalah 84.62% dan 94.03%. Nilai 
ramalan positif (PPV) untuk ultrasound adalah 73.33% dan nilai ramalan negatif (NPV) 
adalah 96.92%. Dari segi morbiditi, pesakit dengan “placenta accreta‟ mengalami lebih 
banyak kehilangan darah, lebih kadar histerektomi dan kadar kemasukan ke ICU, lebih 
tinggi bilangan transfusi darah utuh dan produk darah, serta lebih lama memerlukan 
rawatan di wad hospital. Lebih ramai bayi dalam kumpulan accreta telah dimasukkan ke 
NICU.  
Kesimpulan:  
Placenta accreta dikaitkan dengan morbiditi yang tinggi berbanding “placenta praevia” 
sahaja. Ultrasound adalah alat diagnostik yang baik di dalam membuat diagnosis 
“placenta accreta”. Penemuan ini adalah konsisten dengan kajian lain. 
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ABSTRACT 
Objectives  
The aim of this study is to determine the sensitivity and specificity of ultrasonography in 
the antenatal diagnosis of placenta accreta in patients with placenta praevia and 
previous uterine surgery and to compare the morbidity associated with placenta accreta 
to that of placenta praevia alone.  
 
Methodology:  
This was a retrospective cohort study with the study population consisted of women with 
diagnosis of placenta praevia with previous uterine surgery, such as Caesarean 
section(s), dilatation and curettage (D&C), myomectomy or retained placenta who 
delivered at Hospital Universiti Sains Malaysia between January 2005 and December 
2015. The hospital records system was used to identify all patients with the diagnosis of 
placenta praevia with previous uterine surgery, diagnosed after 28 weeks of gestation. 
Hospital charts were then traced and reviewed for data collection. The sensitivity, 
specificity, positive predictive value (PPV) and negative predictive value (NPV) of 
ultrasound in the diagnosis of placenta accreta were calculated.  
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Results:  
Out of 80 patients included in the study, 15 (18.75%) of them were confirmed to have 
placenta accreta. The sensitivity and specificity of ultrasound in the diagnosis of 
placenta accreta were 84.62% and 94.03%, respectively. The positive predictive value 
(PPV) for ultrasound was 73.33% and the negative predictive value (NPV) was 96.92%. 
In terms of morbidity, patients with placenta accreta had significant intraoperative blood 
loss, hysterectomy rate, ICU admission rate, number of packed cells and DIC regime 
transfusions and longer hospital stay. More neonates in the accreta group required 
NICU admission. 
 
Conclusions:  
Placenta accreta is associated with significant morbidity compared to placenta praevia 
alone. Ultrasound is a good diagnostic tool in the diagnosis of placenta accreta. This 
finding is consistent with other studies. 
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CHAPTER 1: INTRODUCTION 
The incidence of placenta accreta is on the rise, owing to the increasing number of 
Caesarean sections. The incidence of placenta accreta has steadily increased in recent 
decades, from 1 in 2510 pregnancies in the early 1980s to 1 in 533 pregnancies in the 
period 1982–2002 (Esakoff, 2015). It is a potential life threatening condition, and 
associated with significant morbidity and mortality to the patients. Multidisciplinary 
approach is fundamental when it comes to strategies to minimise the complications 
(Eller et al., 2011).  
Placenta accreta is a general term used to describe the clinical condition when the 
entire placenta or part of it is adherent to the uterine wall without easy separation 
(Obstetricians and Gynecologists, 2012). The term placenta increta is used when the 
chorionic villi invade only the myometrium. Placenta percreta occurs when the invasion 
of placenta goes through the myometrium and serosa, and may sometimes invade to 
the adjacent organs, such as the urinary bladder. The diagnosis can be made by grey 
scale, colour or power Doppler sonography with or without magnetic resonance imaging 
(MRI), and is confirmed by evidence of gross placental invasion during surgery or 
histopathological examination.  
It is important to make an accurate diagnosis to facilitate appropriate perioperative 
preparations, to reduce the morbidity to the patients. Studies have shown that 
ultrasonography is a good and inexpensive diagnostic tool to diagnosis placenta 
accreta. However, the fact that it is operator dependent may be a factor which affects its 
effectiveness. Therefore, this study was performed to evaluate the effectiveness of the 
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usage of ultrasound to diagnose placenta accreta among patients with placenta praevia 
with previous uterine surgery in Hospital Universiti Sains Malaysia (Hospital USM), 
which is one of the two tertiary centers in the state of Kelantan. Should it as effective as 
what was found in previous studies, it could be used as a reliable tool for such diagnosis 
thus facilitate in the counseling of the patients and extensive preparation for the 
operation to reduce the patients’ morbidity. 
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CHAPTER 2: LITERATURE REVIEW 
2.1 THE PLACENTA  
Historically, the early Egyptians had already recognised and venerated the placenta.  
The term “Placenta” was first introduced by Realdus Columbus in 1559 during the 
Renaissance, which was derived from a Latin word meaning a “flat cake.” A Greek 
physician called Diogenes of Apollonia (ca. 480 BC) was the first person who described 
the function of fetal nutrition to the organs. Prior to that, Aristotle (384322 BC) had 
proposed that the fetus is fully enclosed within the chorion membranes (Edmonds, 
2011).  
The placenta is a discoid organ that weighs an average of 470 grams in which it is 
proportional to the fetus weight (Frank and Kaufmann, 2006). At term, the fetal to 
placental ratio is seven when determined by weight. The placenta is formed from the 
merger of the chorion and the allantois during early pregnancy and after the third stage 
of labour, it is called the “chorioallantoic placenta.” The decidua is the endometrium of 
pregnancy, arising as a result of a progesterone effect. The attachment site of the 
chorioallantoic placenta onto the uterus is at the decidua basalis, or basal plate, or also 
known as the maternal surface. The placenta exhibits about 10-40 irregularly shaped 
indentations called “cotyledons”, and each cotyledon is supplied by the major branches 
of the umbilical circulation (Rampersad et al., 2011).  
2.2 THE DEVELOPMENT OF PLACENTA  
The development of placenta comprises a complex system. It begins when the fertilised 
ovum reaches the uterine cavity as morula, which rapidly converts into a blastocyst. 
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Following attachment to the endometrium, the outer layer of the blastocyst proliferates 
to form the trophoblastic cell mass which subsequently infiltrates the endometrial 
epithelium, causing the latter to degenerate and the trophoblast thus comes into direct 
contact with the endometrial stroma. In the seventh day, the trophoblast differentiates 
into two layers, an inner layer of mononuclear cytotrophoblastic cells in which mitotic 
figures are seen, and an outer layer of multinucleated syncytiotrophoblast. The 
multinucleated syncytiotrophoblast is in direct contact with maternal tissues, while the 
mononucleated cytotrophoblast as the stem cell layer of the trophoblast is directed 
towards the embryo. All of the differentiation and developmental stages of the placenta 
described so far occur before fluid-filled spaces within the syncytiotrophoblast can be 
detected. This stage is termed prelacunar stage.  
The lacunar stage begins at day eight to nine post-conception, when the 
syncytiotrophoblast generates a number of fluid-filled spaces within the mass. These 
spaces flow together to form larger lacunae and are finally separated by parts of the 
syncytiotropoblast called trabeculae that cross the syncytial mass from the embryonic to 
the maternal side. These trabecular columns are not true villi but serve as the 
framework from which villi will then develop. The trabeculae are therefore best termed 
„primary villous stems” (Boyd and Hamilton, 1970)  
The lacunar system divides the placenta into three compartments. The first 
compartment is the chorionic plate, in which the embryonic part of the trophoblast will 
develop into. The second compartment is the intervillous space, anchoring villi and 
floating villi, formed by the lacunae, trabeculae and the growing braches, respectively. 
The third compartment is the basal plate, formed by the maternally oriented part of the 
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trophoblast. At the end of this stage, the implantation process is completed at day 
twelve post-conception. The developing embryo is totally embedded in the endometrium 
and the syncytiotrophoblast surrounds the whole surface of the conceptus (Boyd and 
Hamilton, 1970).  
Following this stage, the primary, secondary and finally, the tertiary villi were formed. 
Only later, the connection to the fetal vessel system will be established. The villi are 
organized in villous trees that cluster together into a series of spherical units known as 
lobules or placentones. Each placentone originates from the chorionic plate by a thick 
villous trunk stemming from a trabecula. Continuous branching of the main trunk results 
in daughter villi mostly freely ending in the intervillous space.  
2.3 ABNORMAL IMPLANTATION AND ITS SEQUELAE  
Normally, the human blastocyst implants in the upper portion of the uterus. 
Nonetheless, abnormal implantation is common and can lead to pregnancy 
complications such as placenta praevia, which is often associated with placenta 
accreta. The term “placenta praevia” refers to the location of placenta over the internal 
os. It is the principal cause of life-threatening bleeding during the third trimester which 
often warrants an emergency Caesarean section. Many authors concluded that 
previous Caesarean section predisposes to placenta praevia and antenatal 
haemorrhage. Other contributing factors are previous termination of pregnancy by 
uterine curettage, advanced maternal age, multiparity and cigarette smoking (Laughon 
et al., 2005).  
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Placenta accreta was first defined by as the abnormal adherence, either in whole or in 
part, of the afterbirth to the underlying uterine wall‟ (Irving and Hertig, 1937). The 
pathological basis is that the villous tissue had not been attached to the decidua, but it 
had grown onto the myometrium without intervening decidua. There is evidence that 
placenta accreta is due to the failure of normal decidua to form, usually because the 
endometrium is deficient and cannot transform (Irving and Hertig, 1937).  
There are several subdivisions of this condition. If the placenta villi are attached to the 
myometrium but do not invade the muscle it is classified as “placenta accreta vera”. 
“Placenta increta‟ occurs when the villi invade the muscle, whereas if the villi penetrate 
through the full thickness of the myometrium, it is termed “placenta percreta”. In this 
study, all of these varieties will be termed as “placenta accreta‟.  
2.4 RISK FACTORS AND COMPLICATIONS OF PLACENTA ACCRETA  
Placenta accreta is a rare condition that can lead to significant maternal morbidity and 
mortality. Among the identified risk factors are previous Caesarean section, placenta 
praevia, previous dilatation and curettage (D&C), previous myomectomy, high gravidity 
and parity as well as age (Chou MM, 2000; Comstock CH, 2013). The consequences 
are often Caesarean hysterectomy, end of fertility, massive obstetric haemorrhage, 
coagulopathy, injury to surrounding organs and ICU admission. Esakoff et al reported 
that women with placenta accreta had higher estimated blood loss, increased need for 
blood transfusion and longer hospital stay (Esakoff TF, 2011). These complications are 
devastating to the patients and may also lead to other complications such as transfusion 
reaction, infections and deep venous thrombosis.   
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2.5 INCIDENCE OF PLACENTA ACCRETA  
The incidence of placenta accreta is on the rise. It affects approximately 1 in 588 
women (Meng XY, 2013). Owing to the increasing rate of Caesarean delivery, the 
incidence of both placenta praevia and placenta accreta is steadily increasing in 
frequency. The incidence of placenta accreta in the presence of placenta praevia 
increases from 24% after one Caesarean section, up to 47%, 40% and 67% after two, 
three and four Caesarean sections respectively (Kean L, 2010).  
2.6 DIAGNOSIS OF PLACENTA ACCRETA  
Placenta accreta is often diagnosed after the delivery of baby, when placenta fails to be 
delivered (Kayem G, 2013). Attempt to force the delivery may result in severe 
postpartum haemorrhage which warrants emergency hysterectomy. Some may result in 
maternal death. Therefore, it is of paramount importance that accurate diagnosis to be 
established antenatally to minimise the complications. Tikkanen et al reported that 
women with antenatal diagnosis of placenta accreta had a lower estimated blood loss 
and required fewer units of packed red blood cells (Tikkanen M, 2011).  
According to many previous studies, the antenatal diagnosis of placenta accreta can be 
accurately made by ultrasound (Chalubinski KM, 2013). Many studies had evaluated the 
accuracy of ultrasound using the grey-scale, colour Doppler and even three-dimensional 
(3D) sonography. The grey-scale sonography criteria suggestive of placenta praevia 
accreta include a loss of the normally visible retroplacental hypoechoeic zone, the 
presence of multiple lakes that represent dilated vessels extending from the placenta 
through the myometrium (“Swiss cheese” appearance of the placenta), thinning or focal 
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disruption of the uterine serosa-bladder wall complex and focal mass-like elevation of 
tissue with the same echogenicity of the placenta beyond the uterine serosa (Japaraj et 
al., 2007). The colour Doppler and power Doppler criteria suggestive of placenta 
praevia accreta are dilated vascular channels with diffuse lacunar flow, interphase 
hypervascularity with abnormal vessels linking the placenta to the bladder and dilated 
peripheral subplacental vascular channel with pulsatile venous type flow over the 
uterine cervix (Japaraj et al., 2007).  
Previous studies reported the ultrasound sensitivity of 77-93%, specificity of 71-97%, 
positive predictive value (PPV) of 65-88% and negative predictive value (NPV) of 92-
98% in the diagnosis of placenta accreta (Esakoff TF, 2011). In a study comparing 3D 
power Doppler with grey-scale and colour Doppler ultrasonography, the sensitivity of 3D 
power Doppler was reported to be 97% with specificity of 92%.(Shih JC, 2009) This was 
based on best single criterion characterised by “numerous coherent vessels” visualised 
by 3D power Doppler (Shih JC, 2009).  
Nonetheless, the use of ultrasound is operator dependent and its accuracy has not 
been tested at local setting. It is important to make a prompt and accurate diagnosis of 
placenta accreta as patients can be exposed to potential morbidity and mortality. 
Hence, this study is performed.  
Magnetic resonance imaging (MRI) is another imaging modality to diagnose placenta 
accreta but it is more expensive. In a meta-analysis comparing the value of ultrasound 
and MRI, it was found that there is no significant difference between the two modalities 
in the diagnosis of placenta accreta (Meng XY, 2013). At present, the role of MRI is to 
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complement, rather than replace, information obtained via standard sonographic 
imaging (Japaraj et al., 2007).  
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CHAPTER 3: OBJECTIVES 
3.1 OBJECTIVES 
The objectives of this study are:  
1. To determine the incidence of placenta accreta among patients with placenta praevia 
with previous uterine surgery in Hospital USM between January 2005 and December 
2014.  
2. To determine the sensitivity and specificity of ultrasound findings as compared to 
intraoperative findings in the diagnosis of placenta accreta.  
3.2 RESEARCH QUESTIONS  
1. How accurate is the ultrasonography in diagnosing placenta accreta?  
2. What is the morbidity of placenta accreta as compared to placenta praevia without 
accreta?  
3.3 RESEARCH HYPOTHESIS 
Antenatal ultrasound which is performed in Hospital USM is an accurate diagnostic tool 
to diagnose placenta accreta among patients with placenta praevia with previous 
uterine surgery. 
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CHAPTER 4: METHODOLOGY 
4.1 STUDY DESIGN, SETTING AND DURATION  
This study was a retrospective study with the aim to determine the accuracy of 
ultrasonography in the antenatal diagnosis of placenta accreta. This study was 
conducted in Hospital USM for 18 months’ duration, from 1st January 2015 till 1st of June 
2016. A total of 80 patients were included in the study.  
4.2 STUDY POPULATION  
The study population consisted of women with a diagnosis of placenta praevia with 
previous uterine surgery including previous Caesarean section(s), D&C, myomectomy 
or retained placenta who delivered at Hospital USM, from 1st January 2005 until 31st 
December 2015.  
4.3 SAMPLE SIZE CALCULATION  
The sample size was calculated using sample size calculator for sensitivity and 
specificity (MY, 2015), using the formula as below, 
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with: 
 Expected sensitivity of 97% (Shih JC, 2009) 
 Expected specificity of 92% (Shih JC, 2009) 
 Prevalence of 23% (Shih JC, 2009) 
 Desired precision: 0.09 
 Confidence level: 95% 
With that calculation, a total sample size of 77 was required. In this study, a total of 80 
patients were recruited. 
4.4 INCLUSION AND EXCLUSION CRITERIA  
4.4.1 Inclusion Criteria 
1. Patients diagnosed with placenta praevia after 28 weeks 
2. Patients with previous history of uterine surgery 
4.4.2 Exclusion criteria 
Patients in whose files have inadequate data were excluded from the study. 
4.5 STUDY METHODS 
The study was approved by the Ethics Committee of Hospital USM, as in Appendix 1.  
The hospital electronic records were used to identify all patients with the diagnosis of 
placenta praevia diagnosed after 28 weeks with previous uterine surgery. Hospital 
charts were then traced and reviewed for data collection.  
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Placenta accreta was diagnosed antenatally using both greyscale and Doppler 
ultrasonography. The grey-scale features which were previously reported to diagnose 
placenta accreta (as shown below) were used to diagnose placenta accreta (Japaraj et 
al., 2007):  
1. A loss of the normally visible retroplacental echolucent zone  
2. The presence of multiple lakes that represent dilated vessels extending from the 
placenta through the myometrium (“Swiss cheese” appearance of the placenta)  
3. Thinning or focal disruption of the line between the uterus and the bladder  
4. Focal mass-like elevation of tissue with the same echogenicity of the placenta beyond 
the uterine serosa 
Patients with the suspicion of placenta accreta had colour Doppler ultrasound 
performed to confirm the diagnosis. The features of colour Doppler used to diagnose 
placenta accreta were as follows (Japaraj et al., 2007): 
1. Dilated vascular channels with diffuse lacunar flow  
2. Interphase hypervascularity with abnormal vessels linking the placenta to the bladder  
3. Dilated peripheral subplacental vascular channel with pulsatile venous type flow over 
the uterine cervix  
If the ultrasound findings remained inconclusive, patient were subjected for Magnetic 
Resonance Imaging (MRI). These patients were not included in this study. 
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If the ultrasound findings were inconclusive, patient were subjected for Magnetic 
Resonance Imaging (MRI).  
The diagnosis by ultrasound was then confirmed with the intraoperative diagnosis of 
placenta accreta, which was considered as the gold standard diagnosis.  
The medical records were also used to look at the morbidity of patients diagnosed with 
placenta praevia with accreta and those without accreta. The factors which were looked 
into were the need for Caesarean hysterectomy, the estimated blood loss and numbers 
of packed cells used, the need for disseminated intravascular coagulopathy (DIC) 
regime, the need for intensive care unit (ICU) admission, the timing of delivery (elective 
versus emergency delivery) and the urinary bladder involvement. The neonatal 
outcomes including the Apgar score at five minutes and neonatal ICU admissions were 
also analysed.  
4.6 STATISTICAL ANALYSIS 
Data that were obtained in the study were entered, cleaned and analysed using SPSS 
version 20 (IBM Armonk, New Jersey, US) and STATA Version 14. The sensitivity, 
specificity, positive predictive value (PPV) and negative predictive value (NPV) were 
calculated using the formula below: 
Presence of Placenta 
Accreta by Ultrasound 
Diagnosis of Placenta Accreta at operation 
Yes No 
Yes True positive (TP) False positive (FP) 
No False negative (FN) True negative (TN) 
 
[15] 
 
Sensitivity = TP/(TP + FN) x 100% 
Specificty = TN/(FP + TN) x 100% 
PPV = TP/ (TP + FP) x 100% 
NPV = TN/ (TN + FN) x 100% 
The morbidity of placenta accreta was assessed based on a few variables. The 
independent t-test analysis was used to analyse the estimated blood loss, the number 
of packed cells used, and the length of hospital stay. The Chi square test was used to 
analyse Caesarean hysterectomy, admission to intensive care unit (ICU), disseminated 
intravascular coagulopathy (DIC) regime requirement, the timing of Caesarean section 
(elective versus emergency) and the intraoperative bladder involvement/injury. 
4.7 STUDY FLOW CHART 
The study flow chart is as shown in Figure 4-1. 
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Figure 4-1: Study Flow Chart 
  
Approval from institutional ethics committee 
Patients were identified via delivery databases at labour room 
and operation theatres 
Data analysis 
Medical records were traced from the Records Office 
Written permission from Hospital Director for 
access to medical records 
Case notes were reviewed to look for ultrasound findings and 
these were compared with intraoperative ± histopathological 
findings  
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CHAPTER 5: RESULTS 
5.1 DEMOGRAPHIC DATA 
A total of 80 patients diagnosed to have placenta praevia with previous uterine surgery 
were recruited into the study. Almost all the patients were Malays except one patient 
who was a Sikh (n=79; 98.8% and n=1; 1.2% respectively). The mean age of the 
patients was 35.45 ± 4.70 years. Most of the patients were overweight with the mean 
body mass index (BMI) was 27.71 ± 5.48kg/m2.  
Majority of the patients were Para 3 to 5, which was followed by Para 1 to 2. The mean 
parity of the patients was 2.83 ± 1.98. The mean gestational age when the diagnosis of 
placenta accreta was made was 33.86 ± 2.66 weeks, while the mean gestational age at 
delivery was 36.49 ± 2.12 weeks.  
The demographic data of the patients is as summarized in Table 5.1. 
  
[18] 
 
Table 5.1: Demographic data 
Variables Frequency (n) Percentage (%) Mean ± SD 
Age (years)   35.45 ± 4.70 
Ethnicity: 
- Malay 
- Sikh 
 
79 
1 
 
98.8 
1.2 
 
BMI (kg/m2)   27.71 ± 5.48 
- 18.5- 24.9 29 36.3  
- 25.0- 29.9 31 38.8  
- 30.0- 34.9 13 16.3  
- 35.0- 39.9 4 5.0  
- >39.9 3 3.8  
Parity   2.83 ± 1.98 
- Nulliparous 5 6.3  
- Para 1-2 32 40.0  
- Para 3-5 36 45.0  
- Para 6 and above 7 8.8  
Gestational age at 
diagnosis of placenta 
accreta 
  33.86 ± 2.66 
Gestational age at 
delivery 
  36.49 ± 2.12 
[19] 
 
5.2 INCIDENCE OF PLACENTA ACCRETA 
Out of 80 patients, 15 patients (18.8%) were confirmed to have placenta accreta, as 
seen during the operation (Figure 5-1).  
 
Figure 5-1: Incidence of placenta accreta 
 
From this, one patient had previous history of MRP, four patients with one previous 
LSCS, four with two previous LSCS, two patients with three previous LSCS, one patient 
with four previous LSCS, one patient with one previous LSCS and two D&Cs, one with 
two previous LSCS and one D&C and one patient with two previous LSCS and one 
MRP. Table 5.1 shows the incidence of placenta accreta in relation to the number and 
type of uterine surgery the patients had undergone. 
n=15 (18.8%) 
n=65 (81.2%) 
INCIDENCE OF PLACENTA ACCRETA 
Placenta accreta
No placenta accreta
[20] 
 
Table 5.2: Incidence of placenta accreta in relation to the number and type of 
uterine surgery 
 
Number of previous 
uterine surgery 
n Percentage 
D&C alone 0 0.0 
MRP alone 1 6.7 
1 previous LSCS 5 33.3 
2 previous LSCS 6 40 
3 previous LSCS 2 13.3 
4 previous LSCS 1 6.7 
LSCS + D&C 3 20 
LSCS + MRP 1 6.7 
 
The timing of operation, either emergency or elective operation was analysed. 10 
patients had undergone emergency operation, while only 5 had undergone elective 
operation.  
 
[21] 
 
5.3 DIAGNOSIS OF PLACENTA ACCRETA BY ULTRASOUND 
From the 80 patients who were recruited into the study, 13 patients were diagnosed to 
have placenta accreta by ultrasound during the antenatal period. Out of this, 11 patients 
were confirmed to have placenta accreta intraoperatively (Table 5.3). 
Table 5.3:  Diagnosis of placenta accreta by ultrasound 
Intraoperative placenta 
accreta 
Placenta accreta by 
ultrasound 
Total 
Yes No 
Yes 
No 
11 
2 
4 
63 
15 
65 
Total 13 67 80 
 
  
[22] 
 
The sensitivity of ultrasound to diagnose placenta accreta is therefore as follows: 
Sensitivity =          TP     x 100% 
  TP    +    FN 
       =          11              x 100% 
                       11     +    3 
       =  85.0% 
The specificity of ultrasound to diagnose placenta accreta is: 
Specificity =          TN     x 100% 
  FP    +    TN 
       =          63              x 100% 
                             67 
       =  94.0% 
PPV of ultrasound to diagnose placenta accreta: 
PPV       =          TP     x 100% 
  TP    +    FP 
       =          11              x 100% 
                             15 
       =  73.0% 
[23] 
 
NPV of ultrasound to diagnose placenta accreta: 
NPV =          TN     x 100% 
  TN    +    FN 
       =          63              x 100% 
                             67 
       =  94.0% 
 
5.4 THE MORBIDITY OF PLACENTA ACCRETA 
Although the maternal and perinatal morbidity is not one of the objectives, it is 
interesting to know whether the timing of operation, either emergency or elective 
surgery, and the degree of placenta adherence affect the outcome of the mother and 
newborn. As seen in the summary provided in Table 5.4, the timing of operation did not 
associated with the estimated amount of blood loss, so as the degree of placenta 
adherence. Neither the timing of operation nor the degree of placenta adherence affects 
the outcome of the newborn as well. Most of the newborns had good Apgar score. Only 
3 newborns were intubated for severe prematurity. 
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Table 5.4: Placenta accreta in association with maternal and neonatal morbidity 
 
